• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

OPINT

OPINT stands for Operational Intelligence

  • About
  • Sponsored Post
  • Make a Contribution
  • Contact

HealthVerity Raises $100M to Scale IPGE Platform, Market-Leading Technology and Real-World Data Infrastructure

June 28, 2021 By admin Leave a Comment

The Series D round, led by Durable Capital Partners LP, will help scale platform capabilities, enabling secure data exchange across the broadest ecosystem.

PHILADELPHIA – HealthVerity announced today the close of $100 million in Series D funding to accelerate the growth of its IPGE (Identity, Privacy, Government and Exchange) platform. This latest round of funding, led by Durable Capital Partners LP, with participation from all existing investors including Flare Capital Partners, Foresite Capital and Greycroft will help HealthVerity meet the increasing demand for its critical technologies empowering the health insights economy. Beyond accelerating go-to-market initiatives, the financing will fund expansion of the already existing largest real-world data ecosystem and industry-leading patient identity resolution technology.

“We are excited to partner with HealthVerity as it continues to build the next generation of modern technologies that will support the shift towards increased real-world data governance and privacy needs within healthcare,” said Henry Ellenbogen, Managing Partner & Chief Investment Officer at Durable Capital Partners LP. “After witnessing its growth over the past few years, I believe HealthVerity is uniquely positioned to provide solutions for many of the challenges around identity, privacy and governance that will help life sciences, payers and government agencies power secure and private data exchange across an array of patient-centric use cases. It has the potential to be a significant company.”

“Durable’s goal of partnering with high-growth, long-term transformative companies directly aligns with our mission at HealthVerity, where we have been consistent since our inception in our strategy and approach to evolving the healthcare data ecosystem and supporting our clients as they shift towards patient-centricity,” said Andrew Kress, CEO at HealthVerity. “We are so pleased to have them join the HealthVerity team.“

HealthVerity’s IPGE platform provides a unified infrastructure granting more than 250 leading healthcare enterprises and more than 80% of top pharmaceutical companies the ability to confidently leverage the technical capabilities of Identity, Privacy, Governance and Exchange to discover, access and apply real-world healthcare data to a multitude of use cases. Over the past year, HealthVerity’s growth has been accompanied by the selection from the Department of Health and Human Services (HHS) to deliver Privacy Preserving Record Linkage (PPRL) integrated in the COVID-19 vaccine rollout and partnerships with the FDA and NIH on multiple COVID-19 studies.

About Durable Capital Partners
Durable Capital Partners LP (“Durable”) is an investment manager focused on companies that have the potential to compound over time. Durable invests across private and public markets with a long-term horizon, applying deep knowledge of compounder patterns to support leaders building durable and sustainable businesses. Henry Ellenbogen, who previously was Portfolio Manager of T. Rowe Price’s New Horizon Fund, founded Durable in 2019.

About HealthVerity
Pharmaceutical manufacturers, payers and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance and Exchange, enables the discovery of RWD across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy. To learn more about the HealthVerity IPGE platform, visit www.healthverity.com.

Related

Filed Under: News Tagged With: biotech, venture capital

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Opinion

Snitches Get Stitches
Xi Jinping is killing Chinese economy
List of companies that continue to do business with Russia
Restricted exports account for 10% of calories on the global market
What Taiwan can learn from Russia’s invasion of Ukraine
ICYMI: Rubio: A Century of Misery for the Chinese Communist Party
Palestinian journalists plead for protection from Palestinian forces

Press Media Release

Media Digest
Urologists Examine Role of Pollutants, Medications and Testosterone on Men’s Health
Mkt Dev 2022
Media Advisory: Demonstrations of New 5G Research Testbed Thursday at RELLIS
The first pre-commercial version of the smart pole is ready
Governments Spent at Least €93bn on COVID-19 Vaccines and Therapeutics During the Last 11 Months
Callsign is invited to join the World Economic Forum’s Global Innovators Community

Secondary Sidebar

Analysis

Small Business: Access to Capital and Job Creation
Seegene’s COVID-19 test with saliva sample collection feature now available in Europe
Insurtechs driving innovation and disruption in the industry
The Economic Cost of Quarantine
New report identifies 55 high-impact climate technology projects that can help Europe meet 2050 net-zero emissions target

OSINT

Esri Provides Open Access to Key Federal Geospatial Data
Bill Browder on Twitter: “Vladimir Putin issues new ‘kill list’ – and six of the targets, including me, live in Britain
Esri Integrates LightBox Data to Expand Geocoding for Canadian Content
Satellite imagery analysis shows a significant development at Saghand Uranium Mine and Yellowcake Production Plant in Iran
Covid jumped from animals to humans in a notorious Chinese market

Footer

Resent Posts

  • PNSF Director visits the world’s largest experimental earthquake infrastructure facility
  • Rate for shipping a 40ft container from Shanghai to Los Angeles has now fallen by 38%
  • Be a futurist
  • Set shorter deadlines
  • Schedule flexibility is the name of the game
  • Excellent CEOs spin 6 plates at once
  • Macro-Eyes Wins the 2022 xTeachsearch6 Army technology innovation competition
  • For the next 5 years Macron will be scratching around for the votes he needs to get anything done
  • A long and protracted conflict between Western democracies and authoritarian systems
  • ICE Semiconductor Index Selected as Benchmark for Mega International’s New Taiwan-Listed ETF

Media Partners

  • Dossier
  • VC Matters
  • Opinion
  • Press Media Release
  • OSINT
  • Digital Market
  • Briefly

Media Partners

  • Technology Conferences
  • Event Sharing Network
  • Defense Conferences
  • Cybersecurity Events
  • Event Calendar
  • Domain Aftermarkets
  • Domain Market Research
  • S3H
  • VPNW

Copyright © 2018 OPINT.com

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT